CALCULATE YOUR SIP RETURNS

Aster DM Healthcare Shares to Trade Ex-Date on February 10: Interim Dividend of ₹4

Written by: Sachin GuptaUpdated on: Feb 10, 2025, 7:34 PM IST
Aster DM decided to pay an interim dividend of ₹4 within the statutory timeline, declared on January 31, 2025.
Aster DM Healthcare Shares to Trade Ex-Date on February 10: Interim Dividend of ₹4
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

On February 10, 2025, Aster DM shares to trade ex-date, meaning that the shareholders registered in the company’s books will be eligible for the ₹4 interim dividend.

Aster DM Dividend History

Ex-Date Dividend Type Dividend Amount (₹)
Aug 22, 2024 Final 2.00
Apr 23, 2024 Special 118.00

Management Take on Q3FY25 Earnings 

Commenting on the performance for 9M FY25, Dr Azad Moopen, Founder and Chairman, Aster DM Healthcare, said: “We are pleased with the momentum built in the third quarter of FY25, which reflects our unwavering focus on operational excellence and capacity enhancement. For 9M FY25, our India business achieved 15% YoY growth, reaching INR 3,138 crores, driven by increased patient volumes and growth in ARPOB. The Operating EBITDA grew by 35% YoY to ₹613 crores and adjusted net profits (post NCI and excluding merger transaction cost) grew by 65% YoY to ₹251 crores for 9M FY25. A consistent growth across our core businesses, combined with strategic cost optimisation, has significantly strengthened our margins with 9MFY25 Operating EBITDA margins standing at 19.5%.”

Dr Moopen further added, “As we expand, with plans to surpass ~6,800 beds by FY27, Aster DM Healthcare is well-positioned to meet the increasing demand for advanced healthcare in India. I am happy to announce that Aster DM Healthcare was recently honoured at the ASSOCHAM Healthcare Awards 2024, winning the title of “Best Multispecialty Hospital- Group” while Aster DM Foundation secured a 1st runner-up for “Best CSR Excellence in Healthcare”.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: Feb 10, 2025, 8:40 AM IST

Sachin Gupta

Sachin Gupta is a Content Writer with 6+ years of experience in the stock market, including global markets like the US, Canada, and Australia. At Angel One, Sachin specialises in creating financial content that simplifies complex market trends. Sachin holds a Master's in Commerce, specialising in Economics.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 2.5 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 2.5 Cr+ happy customers